News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schuyler Kevin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Bought 700 shares
@ $2.74, valued at
$1.9k
|
|
| 05/25/2023 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.3025, valued at
$15.1k
|
|
| 12/21/2022 |
4
| Schuyler Kevin (Director) has filed a Form 4 on Forza X1, Inc.|
Txns:
| Bought 4,332 shares
@ $1.2, valued at
$5.2k
|
|
| 08/12/2022 |
4
| Schuyler Kevin (Director) has filed a Form 4 on Forza X1, Inc.|
Txns:
| Granted 5,500 options to buy
@ $5, valued at
$27.5k
|
|
| 08/11/2022 |
3
| Schuyler Kevin (Director) has filed a Form 3 on Forza X1, Inc. |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4/A
| Schuyler Kevin (10% Owner) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 89,600 options to buy
@ $5, valued at
$448k
Acquired 89,600 options to buy
@ $5, valued at
$448k
Acquired 89,600 options to buy
@ $6.25, valued at
$560k
Disposed of 192,600 options to buy
@ $5, valued at
$963k
Acquired 192,600 options to buy
@ $5, valued at
$963k
Acquired 192,600 options to buy
@ $6.25, valued at
$1.2M
|
|
| 11/25/2020 |
4/A
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Acquired 89,600 shares
@ $0
Bought 90,000 shares
@ $0
Acquired 144,200 shares
@ $0
Acquired 89,600 options to buy
@ $6.25, valued at
$560k
Bought 90,000 options to buy
@ $6.25, valued at
$562.5k
Acquired 192,600 options to buy
@ $6.25, valued at
$1.2M
Acquired 89,600 options to buy
@ $5, valued at
$448k
Acquired 192,600 options to buy
@ $5, valued at
$963k
|
|
| 11/25/2020 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Gifted 1,010 options to buy
@ $0.0054, valued at
$5.5
Gifted 8,649 options to buy
@ $7.63, valued at
$66k
Gifted 89,600 options to buy
@ $6.25, valued at
$560k
Gifted 82,461 options to buy
@ $6.25, valued at
$515.4k
Gifted 89,600 options to buy
@ $5, valued at
$448k
Gifted 1,010 options to buy
@ $0.0054, valued at
$5.5
Gifted 8,649 options to buy
@ $7.63, valued at
$66k
Gifted 89,600 options to buy
@ $6.25, valued at
$560k
Gifted 82,461 options to buy
@ $6.25, valued at
$515.4k
Gifted 89,600 options to buy
@ $5, valued at
$448k
|
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2018 |
4
| Schuyler Kevin (10% Owner) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 120,000 options to buy
@ $5, valued at
$600k
Acquired 120,000 options to buy
@ $5, valued at
$600k
Acquired 120,000 options to buy
@ $6.25, valued at
$750k
Disposed of 162,200 options to buy
@ $5, valued at
$811k
Acquired 162,200 options to buy
@ $5, valued at
$811k
Acquired 162,200 options to buy
@ $6.25, valued at
$1M
|
|
| 08/02/2018 |
4
| Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.|
Txns:
| Converted 82,461 shares
@ $0
Acquired 120,000 shares
@ $0
Bought 90,000 shares
@ $0
Acquired 113,800 shares
@ $0
Converted 82,461 convertible notes
@ $0.44, valued at
$36.3k
Converted 82,461 options to buy
@ $6.25, valued at
$515.4k
Acquired 120,000 options to buy
@ $6.25, valued at
$750k
Bought 90,000 options to buy
@ $6.25, valued at
$562.5k
Acquired 113,800 options to buy
@ $6.25, valued at
$711.3k
Acquired 120,000 options to buy
@ $5, valued at
$600k
Acquired 162,200 options to buy
@ $5, valued at
$811k
|
|
| 07/26/2018 |
3
| Schuyler Kevin (Director) has filed a Form 3 on ADIAL PHARMACEUTICALS, INC. |
|
|